Decatur Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-587,955
Closed -$14M 102
2016
Q3
$14M Sell
587,955
-151,950
-21% -$3.62M 1.75% 26
2016
Q2
$17.3M Sell
739,905
-31,450
-4% -$680K 2.33% 3
2016
Q1
$14.5M Sell
771,355
-1,225
-0.2% -$21.5K 1.9% 12
2015
Q4
$14.2M Sell
772,580
-4,300
-0.6% -$77.1K 1.83% 21
2015
Q3
$12.7M Sell
776,880
-418,425
-35% -$7.15M 1.74% 28
2015
Q2
$21.2M Sell
1,195,305
-188,100
-14% -$3.36M 2.63% 7
2015
Q1
$24.6M Sell
1,383,405
-118,175
-8% -$1.87M 3.04% 2
2014
Q4
$19.9M Buy
1,501,580
+344,580
+30% +$4.41M 2.66% 7
2014
Q3
$13.7M Buy
1,157,000
+389,975
+51% +$4.91M 2.3% 13
2014
Q2
$9.79M Sell
767,025
-7,825
-1% -$102K 1.85% 18
2014
Q1
$10.5M Sell
774,850
-6,700
-0.9% -$87.9K 2% 10
2013
Q4
$9.39M Sell
781,550
-32,625
-4% -$385K 1.81% 16
2013
Q3
$9.56M Buy
+814,175
New +$8.81M 2.01% 11

Other funds holding BSX

Decatur Capital Management's BSX Position: Q4 2016 in Review

Decatur Capital Management sold out of Boston Scientific (BSX) in Q4 2016, closing a stake of 587,955 shares — an estimated $14M sold.

Decatur Capital Management first reported a position in BSX in Q3 2013 and held it in 13 quarters. The position peaked at $24.6M in Q1 2015. 556 funds tracked by Wall St. Rank hold BSX as of Q4 2016.

  • Decatur Capital Management reported no remaining Boston Scientific position as of Q4 2016 after selling out during the quarter.
  • Decatur Capital Management sold 587,955 Boston Scientific shares in Q4 2016, an estimated $14M.
  • Decatur Capital Management first reported a position in Boston Scientific in Q3 2013 and held it in 13 quarters.
  • Decatur Capital Management's Boston Scientific position peaked at $24.6M in Q1 2015.
  • 556 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2016.

Based on Decatur Capital Management's 13F filing for Q4 2016, filed 6 Feb 2017.